Asymmetry Capital Management

Asymmetry Capital Management as of June 30, 2018

Portfolio Holdings for Asymmetry Capital Management

Asymmetry Capital Management holds 36 positions in its portfolio as reported in the June 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Optinose (OPTN) 9.2 $9.4M 336k 27.98
Vertex Pharmaceuticals Incorporated (VRTX) 8.9 $9.0M 53k 169.96
Ptc Therapeutics I (PTCT) 6.8 $6.9M 205k 33.73
Acadia Healthcare (ACHC) 5.2 $5.2M 128k 40.91
Jazz Pharmaceuticals (JAZZ) 5.0 $5.1M 30k 172.29
EXACT Sciences Corporation (EXAS) 5.0 $5.1M 85k 59.79
Centene Corporation (CNC) 4.7 $4.8M 39k 123.20
Insmed (INSM) 4.6 $4.7M 199k 23.65
UnitedHealth (UNH) 3.5 $3.5M 15k 245.36
Aerie Pharmaceuticals 3.3 $3.4M 50k 67.55
Portola Pharmaceuticals 3.2 $3.3M 87k 37.77
Anaptysbio Inc Common (ANAB) 2.8 $2.9M 41k 71.05
Quest Diagnostics Incorporated (DGX) 2.7 $2.7M 25k 109.95
Viewray (VRAYQ) 2.7 $2.7M 391k 6.92
Neurocrine Biosciences (NBIX) 2.6 $2.6M 27k 98.25
Heron Therapeutics (HRTX) 2.5 $2.6M 67k 38.85
Natera (NTRA) 2.2 $2.2M 119k 18.82
Global Blood Therapeutics In 2.2 $2.2M 49k 45.20
Intercept Pharmaceuticals In 2.1 $2.2M 26k 83.92
Amicus Therapeutics (FOLD) 2.0 $2.1M 132k 15.62
Opko Health (OPK) 1.9 $1.9M 407k 4.70
Bio-Rad Laboratories (BIO) 1.7 $1.7M 5.9k 288.61
Perrigo Company (PRGO) 1.7 $1.7M 23k 72.90
Sarepta Therapeutics (SRPT) 1.5 $1.5M 11k 132.19
Viking Therapeutics (VKTX) 1.4 $1.5M 154k 9.49
Kadmon Hldgs 1.4 $1.4M 362k 3.99
Endocyte 1.4 $1.4M 103k 13.80
Regenxbio Inc equity us cm (RGNX) 1.2 $1.2M 17k 71.77
Verrica Pharmaceuticals (VRCA) 1.2 $1.2M 60k 19.73
Acceleron Pharma 1.1 $1.1M 23k 48.54
DURECT Corporation 1.1 $1.1M 688k 1.56
Neuronetics (STIM) 0.9 $958k 36k 26.61
Nucana Plc american depositary shares (NCNA) 0.9 $910k 48k 19.01
Senseonics Hldgs (SENS) 0.6 $595k 145k 4.11
Immunomedics 0.5 $466k 20k 23.66
Sienna Biopharmaceuticals (SNNAQ) 0.4 $372k 25k 15.17